questionsmedicales.fr
Virus
Virus à ARN
Retroviridae
Lentivirus
Lentivirus ovins-caprins
Virus maedi-visna
Virus maedi-visna : Questions médicales fréquentes
Termes MeSH sélectionnés :
Complement Membrane Attack Complex
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus maedi-visna : Questions médicales les plus fréquentes",
"headline": "Virus maedi-visna : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus maedi-visna : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-20",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus maedi-visna"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lentivirus ovins-caprins",
"url": "https://questionsmedicales.fr/mesh/D017972",
"about": {
"@type": "MedicalCondition",
"name": "Lentivirus ovins-caprins",
"code": {
"@type": "MedicalCode",
"code": "D017972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.650.589.600"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus maedi-visna",
"alternateName": "Visna-maedi virus",
"code": {
"@type": "MedicalCode",
"code": "D014790",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xujie Duan",
"url": "https://questionsmedicales.fr/author/Xujie%20Duan",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Xiaona Shi",
"url": "https://questionsmedicales.fr/author/Xiaona%20Shi",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Shuying Liu",
"url": "https://questionsmedicales.fr/author/Shuying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Stefán R Jónsson",
"url": "https://questionsmedicales.fr/author/Stef%C3%A1n%20R%20J%C3%B3nsson",
"affiliation": {
"@type": "Organization",
"name": "Institute for Experimental Pathology, University of Iceland, Keldur, Reykjavik 112, Iceland."
}
},
{
"@type": "Person",
"name": "Yalçın Yaman",
"url": "https://questionsmedicales.fr/author/Yal%C3%A7%C4%B1n%20Yaman",
"affiliation": {
"@type": "Organization",
"name": "Siirt University Faculty of Veterinary Medicine, Department of Genetics, Siirt, Türkiye."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Complement killing of clinical Klebsiella pneumoniae isolates is serum concentration dependent.",
"datePublished": "2022-11-03",
"url": "https://questionsmedicales.fr/article/36336240",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.micinf.2022.105074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?",
"datePublished": "2022-09-21",
"url": "https://questionsmedicales.fr/article/36211440",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.953674"
}
},
{
"@type": "ScholarlyArticle",
"name": "Unveiling CD59-Antibody Interactions to Design Paratope-Mimicking Peptides for Complement Modulation.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37239905",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24108561"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genome-wide screen in human plasma identifies multifaceted complement evasion of Pseudomonas aeruginosa.",
"datePublished": "2023-01-25",
"url": "https://questionsmedicales.fr/article/36696456",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.ppat.1011023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Klebsiella LPS O1-antigen prevents complement-mediated killing by inhibiting C9 polymerization.",
"datePublished": "2024-09-05",
"url": "https://questionsmedicales.fr/article/39237647",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-71487-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Retroviridae",
"item": "https://questionsmedicales.fr/mesh/D012190"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lentivirus",
"item": "https://questionsmedicales.fr/mesh/D016086"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lentivirus ovins-caprins",
"item": "https://questionsmedicales.fr/mesh/D017972"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus maedi-visna",
"item": "https://questionsmedicales.fr/mesh/D014790"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus maedi-visna - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus maedi-visna",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus maedi-visna",
"description": "Comment diagnostiquer une infection par le virus maedi-visna ?\nQuels tests sont utilisés pour le virus maedi-visna ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer le virus chez les animaux asymptomatiques ?\nQuelle est l'importance du diagnostic précoce ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+Membrane+Attack+Complex&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus maedi-visna",
"description": "Quels sont les symptômes principaux du virus maedi-visna ?\nLes symptômes varient-ils selon l'âge des moutons ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes sont-ils toujours présents ?\nComment évoluent les symptômes au fil du temps ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+Membrane+Attack+Complex&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus maedi-visna",
"description": "Comment prévenir l'infection par le virus maedi-visna ?\nLes tests de dépistage sont-ils efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nLes animaux doivent-ils être vaccinés ?\nComment gérer les nouveaux animaux dans un troupeau ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+Membrane+Attack+Complex&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus maedi-visna",
"description": "Quel est le traitement principal pour le virus maedi-visna ?\nPeut-on utiliser des antiviraux contre ce virus ?\nComment gérer les animaux infectés ?\nY a-t-il des vaccins disponibles ?\nQuel rôle joue la nutrition dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+Membrane+Attack+Complex&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus maedi-visna",
"description": "Quelles complications peuvent survenir avec le virus maedi-visna ?\nLes complications sont-elles fréquentes ?\nComment les complications affectent-elles la production ?\nLes complications sont-elles réversibles ?\nQuel est le pronostic pour les animaux infectés ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+Membrane+Attack+Complex&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus maedi-visna",
"description": "Quels sont les facteurs de risque d'infection ?\nLe stress augmente-t-il le risque d'infection ?\nLes races de moutons sont-elles affectées différemment ?\nL'environnement joue-t-il un rôle dans l'infection ?\nLes pratiques d'élevage influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+Membrane+Attack+Complex&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le virus maedi-visna ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et des analyses PCR pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le virus maedi-visna ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et PCR sont couramment utilisés pour identifier le virus dans le sang."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques comme la pneumonie et l'encéphalite orientent le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer le virus chez les animaux asymptomatiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sérologiques peuvent détecter le virus même sans symptômes visibles."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du diagnostic précoce ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic précoce permet de mieux gérer la maladie et de limiter sa propagation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du virus maedi-visna ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, difficultés respiratoires et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge des moutons ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes animaux peuvent présenter des symptômes plus graves que les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes neurologiques comme des tremblements et des troubles de la coordination peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains animaux peuvent être porteurs sans montrer de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes au fil du temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver progressivement, menant à des complications graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus maedi-visna ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'isolement des animaux infectés et des pratiques d'élevage saines."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier des troupeaux permet de détecter et d'éliminer les animaux infectés."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures d'hygiène strictes, comme le nettoyage des équipements, sont essentielles."
}
},
{
"@type": "Question",
"name": "Les animaux doivent-ils être vaccinés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il n'y ait pas de vaccin, la vaccination contre d'autres maladies est recommandée."
}
},
{
"@type": "Question",
"name": "Comment gérer les nouveaux animaux dans un troupeau ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nouveaux animaux doivent être testés et mis en quarantaine avant d'intégrer le troupeau."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus maedi-visna ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique; la gestion des symptômes est essentielle."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des antiviraux contre ce virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'y a pas d'antiviraux efficaces spécifiquement pour le virus maedi-visna."
}
},
{
"@type": "Question",
"name": "Comment gérer les animaux infectés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les animaux infectés doivent être isolés et traités symptomatiquement pour améliorer leur confort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de vaccin commercialement disponible contre le virus maedi-visna."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la nutrition dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne nutrition peut aider à renforcer le système immunitaire des animaux infectés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le virus maedi-visna ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent pneumonie chronique et encéphalite, pouvant être mortelles."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications sont courantes chez les animaux infectés, surtout sans traitement."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la production ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la productivité des animaux, affectant la rentabilité de l'élevage."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup sont irréversibles et graves."
}
},
{
"@type": "Question",
"name": "Quel est le pronostic pour les animaux infectés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le pronostic dépend de la gravité des symptômes; beaucoup développent des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le stress, et la densité de population dans le troupeau."
}
},
{
"@type": "Question",
"name": "Le stress augmente-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire, augmentant le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les races de moutons sont-elles affectées différemment ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines races peuvent être plus susceptibles à l'infection en raison de leur génétique."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans l'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement surpeuplé et insalubre favorise la propagation du virus."
}
},
{
"@type": "Question",
"name": "Les pratiques d'élevage influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des pratiques d'élevage inadéquates augmentent le risque de transmission du virus."
}
}
]
}
]
}
Klebsiella pneumoniae is an opportunistic gram-negative pathogen causing serious infections, including sepsis. In plasma, activation of the complement cascades is important for killing bacteria. Thirt...
Hidradenitis suppurativa (HS) is a chronic auto-inflammatory skin disease with a complex and multifactorial pathogenesis involving both the innate and adaptive immune system. Despite limited evidence ...
CD59 is an abundant immuno-regulatory human protein that protects cells from damage by inhibiting the complement system. CD59 inhibits the assembly of the Membrane Attack Complex (MAC), the bactericid...
Pseudomonas aeruginosa, an opportunistic Gram-negative pathogen, is a leading cause of bacteremia with a high mortality rate. We recently reported that P. aeruginosa forms a persister-like sub-populat...
The Gram-negative bacterium Klebsiella pneumoniae is an important human pathogen. Its treatment has been complicated by the emergence of multi-drug resistant strains. The human complement system is an...
In myelin oligodendrocyte glycoprotein IgG-associated disease (MOGAD) and aquaporin-4 IgG+ neuromyelitis optica spectrum disorder (AQP4+NMOSD), the autoantibodies are mainly composed of IgG1, and comp...
CSF-C3a, CSF-C4a, CSF-C5a, and CSF-C5b-9 levels during the acute phase before treatment in patients with MOGAD (n = 12), AQP4+NMOSD (n = 11), multiple sclerosis (MS) (n = 5), and noninflammatory neuro...
CSF-C3a and CSF-C5a levels were significantly higher in MOGAD (mean ± SD, 5,629 ± 1,079 pg/mL and 2,930 ± 435.8 pg/mL) and AQP4+NMOSD (6,017 ± 3,937 pg/mL and 2,544 ± 1,231 pg/mL) than in MS (1,507 ± ...
The complement pathway is activated in both MOGAD and AQP4+NMOSD, but MAC formation is lower in MOGAD, particularly in those with mild attacks, than in AQP4+NMOSD. These findings may have pathogenetic...
IgA nephropathy (IgAN) is one of the leading causes of end-stage renal disease (ESRD). Urine testing is a non-invasive way to track the biomarkers used for measuring renal injury. This study aimed to ...
In the discovery phase, we analysed 22 IgAN patients who were divided into three groups (IgAN 1-3) according to their estimated glomerular filtration rate (eGFR). Eight patients with primary membranou...
In the discovery phase, 747 proteins were identified in the urine of IgAN and pMN patients. There were different urine protein profiles in IgAN and pMN patients, and the bioinformatics analysis reveal...
There were abundant complement components in the urine of IgAN patients, indicating that the activation of AP and LP is involved in IgAN progression. Urinary complement proteins may be used as biomark...
The membrane attack complex (MAC or C5b-9) is an important effector of the immune system to kill invading microbes. MAC formation is initiated when complement enzymes on the bacterial surface convert ...
Antibodies play a key role in the immune defence against Gram-negative bacteria. After binding to bacterial surface antigens, IgG and IgM can activate the complement system and trigger formation of ly...
The complement system plays a crucial role in cognitive impairment. The aim of this study is to investigate the correlation between the complement proteins levels in serum astrocyte-derived exosomes (...
In this cross-sectional study, the patients with immune-mediated T1DM were enrolled. Healthy subjects matched for age and sex with T1DM patients were selected as controls. The cognitive function was e...
This study recruited 55 subjects immune-mediated T1DM patients without dementia, including 31 T1DM patients with MCI, 24 T1DM patients without MCI. 33 healthy subjects were enrolled as controls. The r...
The elevated C5b-9 levels in ADEswere significantly associated with theMCI in T1DM patients. The C5b-9 in ADEs may be used as a marker of MCI in T1DM patients....